230 related articles for article (PubMed ID: 21813177)
1. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
[TBL] [Abstract][Full Text] [Related]
2. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
[TBL] [Abstract][Full Text] [Related]
3. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
[TBL] [Abstract][Full Text] [Related]
4. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS
Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623
[TBL] [Abstract][Full Text] [Related]
5. Loss of Pax5 Exploits Sca1-BCR-ABL
Martín-Lorenzo A; Auer F; Chan LN; García-Ramírez I; González-Herrero I; Rodríguez-Hernández G; Bartenhagen C; Dugas M; Gombert M; Ginzel S; Blanco O; Orfao A; Alonso-López D; Rivas JL; García-Cenador MB; García-Criado FJ; Müschen M; Sánchez-García I; Borkhardt A; Vicente-Dueñas C; Hauer J
Cancer Res; 2018 May; 78(10):2669-2679. PubMed ID: 29490943
[TBL] [Abstract][Full Text] [Related]
6. PAX5-ELN oncoprotein promotes multistep B-cell acute lymphoblastic leukemia in mice.
Jamrog L; Chemin G; Fregona V; Coster L; Pasquet M; Oudinet C; Rouquié N; Prade N; Lagarde S; Cresson C; Hébrard S; Nguyen Huu NS; Bousquet M; Quelen C; Brousset P; Mancini SJC; Delabesse E; Khamlichi AA; Gerby B; Broccardo C
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10357-10362. PubMed ID: 30257940
[No Abstract] [Full Text] [Related]
7. [Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].
Lin ZK; Zhang R; Ge Z; Xu JY; Liu J; Guo X; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1206-11. PubMed ID: 25338558
[TBL] [Abstract][Full Text] [Related]
8. PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia.
Shang Z; Zhao Y; Zhou K; Xu Y; Huang W
Int J Hematol; 2013 May; 97(5):599-603. PubMed ID: 23529845
[TBL] [Abstract][Full Text] [Related]
9. One missense mutation in exon 2 of the PAX5 gene in Iran.
Yazdanparast S; Khatami SR; Galehdari H; Jaseb K
Genet Mol Res; 2015 Dec; 14(4):17768-75. PubMed ID: 26782422
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
Nasr MR; Rosenthal N; Syrbu S
Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
[TBL] [Abstract][Full Text] [Related]
12. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
[TBL] [Abstract][Full Text] [Related]
13. Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility.
Martín-Lorenzo A; Hauer J; Vicente-Dueñas C; Auer F; González-Herrero I; García-Ramírez I; Ginzel S; Thiele R; Constantinescu SN; Bartenhagen C; Dugas M; Gombert M; Schäfer D; Blanco O; Mayado A; Orfao A; Alonso-López D; Rivas Jde L; Cobaleda C; García-Cenador MB; García-Criado FJ; Sánchez-García I; Borkhardt A
Cancer Discov; 2015 Dec; 5(12):1328-43. PubMed ID: 26408659
[TBL] [Abstract][Full Text] [Related]
14. [Expression of the transcription factor PAX5 in childhood acute leukemic cells].
Zhang B; Tie LJ; Ye QD; Gu LJ; Tang JY; Yuan XL; Shen LS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):6-10. PubMed ID: 16584581
[TBL] [Abstract][Full Text] [Related]
15. Expression of PAX5 splice variants: a phenomenon of stress-induced, illegitimate splicing?
Nebral K; Krehan D; Strehl S
Br J Haematol; 2011 Oct; 155(2):277-80. PubMed ID: 21480862
[No Abstract] [Full Text] [Related]
16. [Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities].
Liu XM; Zhang L; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Chen XJ; Wang SC; Yang WY; Guo Y; Zou Y; Chen YM; Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Apr; 18(4):287-91. PubMed ID: 27097569
[TBL] [Abstract][Full Text] [Related]
17. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.
Coyaud E; Struski S; Prade N; Familiades J; Eichner R; Quelen C; Bousquet M; Mugneret F; Talmant P; Pages MP; Lefebvre C; Penther D; Lippert E; Nadal N; Taviaux S; Poppe B; Luquet I; Baranger L; Eclache V; Radford I; Barin C; Mozziconacci MJ; Lafage-Pochitaloff M; Antoine-Poirel H; Charrin C; Perot C; Terre C; Brousset P; Dastugue N; Broccardo C
Blood; 2010 Apr; 115(15):3089-97. PubMed ID: 20160164
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis.
Isidro-Hernández M; Mayado A; Casado-García A; Martínez-Cano J; Palmi C; Fazio G; Orfao A; Ribera J; Ribera JM; Zamora L; Raboso-Gallego J; Blanco O; Alonso-López D; De Las Rivas J; Jiménez R; García Criado FJ; García Cenador MB; Ramírez-Orellana M; Cazzaniga G; Cobaleda C; Vicente-Dueñas C; Sánchez-García I
Sci Rep; 2020 Nov; 10(1):19189. PubMed ID: 33154497
[TBL] [Abstract][Full Text] [Related]
19. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
Shah S; Schrader KA; Waanders E; Timms AE; Vijai J; Miething C; Wechsler J; Yang J; Hayes J; Klein RJ; Zhang J; Wei L; Wu G; Rusch M; Nagahawatte P; Ma J; Chen SC; Song G; Cheng J; Meyers P; Bhojwani D; Jhanwar S; Maslak P; Fleisher M; Littman J; Offit L; Rau-Murthy R; Fleischut MH; Corines M; Murali R; Gao X; Manschreck C; Kitzing T; Murty VV; Raimondi S; Kuiper RP; Simons A; Schiffman JD; Onel K; Plon SE; Wheeler D; Ritter D; Ziegler DS; Tucker K; Sutton R; Chenevix-Trench G; Li J; Huntsman DG; Hansford S; Senz J; Walsh T; Lee M; Hahn CN; Roberts K; King MC; Lo SM; Levine RL; Viale A; Socci ND; Nathanson KL; Scott HS; Daly M; Lipkin SM; Lowe SW; Downing JR; Altshuler D; Sandlund JT; Horwitz MS; Mullighan CG; Offit K
Nat Genet; 2013 Oct; 45(10):1226-1231. PubMed ID: 24013638
[TBL] [Abstract][Full Text] [Related]
20. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
